Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 61

  1. Cat.No. Product Name Information/Activity
  2. BCC7755 CHPG Sodium salt CHPG sodium salt is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells. CHPG sodium salt protects against traumatic brain injury (TBI) in vitro and in vivo by activation of the ERK and Akt signaling pathways.. CHPG Sodium salt chemical structure
  3. BCC6613 (RS)-3,5-DHPG 19641-83-9 (RS)-3,5-DHPG chemical structure
  4. BCC6802 (S)-3,5-DHPG 162870-29-3 (S)-3,5-DHPG chemical structure
  5. BCC6604 (RS)-3-Hydroxyphenylglycine 31932-87-3 (RS)-3-Hydroxyphenylglycine chemical structure
  6. BCC6605 (S)-3-Hydroxyphenylglycine 71301-82-1 (S)-3-Hydroxyphenylglycine chemical structure
  7. BCC7653 NPEC-caged-(1S,3R)-ACPD 1315379-60-2 NPEC-caged-(1S,3R)-ACPD chemical structure
  8. BCC6558 S-Sulfo-L-cysteine sodium salt 7381-67-1 S-Sulfo-L-cysteine sodium salt chemical structure
  9. BCC7302 ACDPP hydrochloride 37804-11-8 ACDPP hydrochloride chemical structure
  10. BCC6841 AIDA 168560-79-0 AIDA chemical structure
  11. BCC5915 Bay 36-7620 Non-competitive mGlu<sub>1</sub> antagonist with inverse agonist activity Bay 36-7620 chemical structure

Items 601 to 610 of 709 total